CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation
about
P1343
CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation
description
article
@en
im August 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2018
@uk
name
CRISPR/Cas9 gene editing for t ...... ol HIV-1 vaccine glycosylation
@en
CRISPR/Cas9 gene editing for t ...... ol HIV-1 vaccine glycosylation
@nl
type
label
CRISPR/Cas9 gene editing for t ...... ol HIV-1 vaccine glycosylation
@en
CRISPR/Cas9 gene editing for t ...... ol HIV-1 vaccine glycosylation
@nl
prefLabel
CRISPR/Cas9 gene editing for t ...... ol HIV-1 vaccine glycosylation
@en
CRISPR/Cas9 gene editing for t ...... ol HIV-1 vaccine glycosylation
@nl
P2093
P2860
P1433
P1476
CRISPR/Cas9 gene editing for t ...... ol HIV-1 vaccine glycosylation
@en
P2093
David L Alexander
Meredith Wright
Parastoo Azadi
Phillip W Berman
Qiushi Chen
Rachel C Doran
Sara M O'Rourke
P2860
P304
P356
10.1371/JOURNAL.PBIO.2005817
P407
P577
2018-08-29T00:00:00Z